Elevated levels of hyaluronic acid in the sera of women with fibromyalgia

Journal of Rheumatology

Volumn 24, Issue 11, 1997, Pages 2221-2224

  Yaron, Ilana ^a   Buskila, Dan ^b   Shirazi, Idit ^a   Neumann, Lily ^c   Elkayam, Ori ^a   Paran, Daphna ^a   Yaron, Michael ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Fibromyalgia; Hyaluronic acid

Indexed keywords

HYALURONIC ACID;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FIBROMYALGIA; HUMAN; PRIORITY JOURNAL; RADIOMETRY;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; FEMALE; FIBROMYALGIA; HUMANS; HYALURONIC ACID; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 0030697816     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Goldenberg DL: Fibromyalgia. In: Klippel JK, Dieppe PA, editors. Rheumatology. London: Mosby, 1994;5:16.1-16.12.
2. Wolfe F, Smythe HA, Yunus MB, et al: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 1990;33:160-72.
3. Yunus MB: Towards a model of pathophysiology of fibromyalgia: Aberrant central pain mechanisms with peripheral modulation. J Rheumatol 1992;19:846-50.
4. Russell U: Neurohormonal aspects of fibromyalgia syndrome. Rheum Dis Clin North Am 1989;15:149-65.
5. Russell IJ: Biochemical abnormalities in fibromyalgia syndrome. J Musculoskel Pain 1994;2:101-15.
6. Bennett RM, Clark SR, Campbell SM, Burckhardt CS: Low levels of somatomedin C in patients with the fibromyalgia syndrome: A possible link between sleep and muscle pain. Arthritis Rheum 1992;35:1113-6.
7. Castor CW, Bignall MC, Hossler PA, Roberts DJ: Connective tissue activation. XXI. Regulation of glycosaminoglycan metabolism by lymphocyte (CTAP-I) and platelet (CTAP-III) growth factors. In-Vitro 1981;17:777-85.
8. Sisson JC, Castor CW, Klavons JA: Connective tissue activation. XVIII. Stimulation of hyaluronic acid synthetase activity. J Lab Clin Med 1980;96:189-97.
9. Castor CW: Regulation of connective tissue metabolism by autocoid mediators. J Rheumatol 1983;(suppl)11:55-60.
10. Levesque H, Deplech B, Le Loet X, Deshayes P: Serum hyaluronate in rheumatoid arthritis: Study by affinoimmunoenzymatic assay. Br J Rheumatol 1988;27:445-9.
11. Emlen W, Niebur J, Flanders G, Rutledge J: Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: Correlation with disease activity. J Rheumatol 1996;23:974-8.
12. Brambley PN, Rathbone BJ, Forbes MA, Cooper EH, Losowsky MS: Serum hyaluronate as a marker of hepatic derangement in acute liver damage. J Hepatol 1991;13:8-13.
13. Nyberg A, Engstrom-Laurent A, Loof L: Serum hyaluronate in primary biliary cirrhosis - A biochemical marker for progressive liver damage. Hepalology 1988;8:142-6.
14. Arnett FC: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;241:1218-21.
15. Tengblad A: Quantitative analysis of hyaluronate in nanogram amounts. Biochem J 1980;185:101-5.
16. Brandt R, Hedlöf E, Asman I, Bucht A, Tengblad A: A convenient radiometric assay for hyaluronan. Acta Otolaryngol 1987;(suppl)442:31-5.
17. Laurent UBG, Tengblad A: Determination of hyaluronate in biological samples by a specific radioassay technique. Analytical Biochem 1980;109:386-94.
18. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L: The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28.
19. Smythe HA: "Fibrositis" as a disorder of pain modulation. Clin Rheum Dis 1979;5:823-32.
20. Smythe HA: Tender points: Evolution of concepts of the fibrositis/fibromyalgia syndrome. Am J Med 1986;(suppl 3A)81:2-6.
21. Reynolds MD: The development of the concept of fibrositis. J Hist Med Allied Sci 1983;38:5-35.
22. Muller W: The fibrositis syndrome: Diagnosis, differential diagnosis and pathogenesis. Scand J Rheumatol 1987;65:40-53.
23. Yunus MB, Masi AT, Calabro JJ, Miller KA, Feigenbaum SL: Primary fibromyalgia (fibrositis): Clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 1981;11:151-71.
24. Hudson JI, Pope HG: Fibromyalgia and psychopathology: Is fibromyalgia a form of "affective spectrum disorder"? J Rheumatol 1989;16:15-22.
25. Ahles TA, Khan SA, Yunus MB, Spiegel DA, Masi AT; Psychiatric status of patients with primary fibromyalgia, patients with rheumatoid arthritis and subjects without pain: A blind comparison of DSM-III diagnoses. Am J Psychiat 1991;148:1721-6.
26. Moldofsky H, Scarisbrick P: Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom Med 1976;38:35-44.
27. Moldofsky HA: Sleep and fibrositis syndrome. Rheum Dis Clin North Am 1989;15:15-20.
28. Yunus MB, Kalyan-Raman UP, Masi AT, Aldag JC: Electron microscopic studies of muscle biopsy in primary fibromyalgia syndrome. A controlled and blinded study. J Rheumatol 1989;16:97-101.
29. Simms RW: Muscle studies in fibromyalgia syndrome. J Musculoskel Pain 1994;2:117-23.
30. Yunus MB, Dailey JW, Aldag JC, et al: Plasma tryptophan and other amino acids in primary fibromyalgia: A controlled study. J Rheumatol 1992;19:90-4.
31. Buskila D, Fefer P, Harman-Boehm I, et al: Assessment of monarticular tenderness and prevalence of fibromyalgia in hyperprolactinemic women. J Rheumatol 1993;20:2112-5.
32. Vaeroy H, Helle R, Forre O, Kass E, Terenius L: Elevated CSF levels of substance P and high incidence of Raynaud's phenomenon in patients with fibromyalgia: New features for diagnosis. Pain 1988;32:21-6.
33. Buskila D, Neumann L, Carmi R: Analysis of genetic aspects in fibromyalgia families (abstr). J Musculoskel Pain 1995; (suppl 1)3:50.
34. Buskila D, Gladman DD, Langevitz P, Urowitz S, Smythe HA: Fibromyalgia in human immunodeficiency virus infection. J Rheumatol 1990;17:1202-6.
35. Buchwald D, Goldenberg DL, Sullivan JL, Komaroff AL: The chronic, active Epstein-Barr virus infection syndrome and primary fibromyalgia. Arthritis Rheum 1987;30:1132-6.
36. Goldenberg DL: Fibromyalgia and other chronic fatigue syndromes: Is there evidence for chronic viral diseases? Semin Arthritis Rheum 1988;18:111-20.
37. Engstrom-Laurent A, Feltelius N, Hallgren R, Wastenson A: Raised serum hyaluronate levels in scleroderma: An effect of growth factor induced activation of connective tissue cells? Ann Rheum Dis 1985;44:614-20.
38. Longaker MT, Adzick NS, Sadigh D, et al: Hyaluronic acid stimulating activity in the pathophysiology of Wilms' tumors. J Natl Cancer Inst 1990;82:135-9.
39. Castor CW, Cabral AR: Connective tissue activating peptides. Methods Enzymol 1988;163:731-48.
40. Cabrai AR, Hewett-Emmett D, Welty RJ, Castor CW: Effects of human carbonic anhydrase III (CA III) on synovial and muscle fibroblast glycosaminoglycan metabolism. Proc Soc Exp Biol Med 1987;184:24-30.
41. Castor CW, Fremuth TD, Furlong AM, Jourdian GW: Hyaluronic acid and proteoglycan synthesis by lung fibroblasts in basal and activated states. In-Vitro 1983;19:462-70.
42. Yaron I, Meyer FA, Dayer JM, Bleiberg I, Yaron M: Some human recombinant cytokines stimulate glycosaminoglycan synthesis in human synovial fibroblast cultures and inhibit it in human articular cartilage cultures. Arthritis Rheum 1959;32:173-80.
43. Meyer FA, Yaron I, Yaron M: Synergistic, additive and antagonistic effects of interleukin-1β, tumor necrosis factor and γ-interferon on prostaglandin E, hyaluronic acid and collagenase production by cultured synovial fibroblasts. Arthritis Rheum 1990;33:1518-25.
44. Yaron M, Yaron I, Levita M, Herzberg M: Hyaluronic acid produced by irradiated human synovial fibroblasts. Arthritis Rheum 1977;20:702-8.